Description: | (3S,4S)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (3S,4S)-Tivantinib has two novel targets, GSK3? and GSK3?, which play an important role in the cellular mechanism of non-small cell lung cancer (NSCLC)[1]. |